Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.000p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 6.00p
  • 52 Week Low: 2.00p
  • Currency: UK Pounds
  • Shares Issued: 697.20m
  • Volume: 0
  • Beta: 1.02

Latest Deals

Traded Action Notifier PriceAmountValue
25-Jun-25 Buy Cathal Friel 2.50p 4,000,000 £100,000.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
25-Jun-25 Buy Cathal Friel 2.50p 4,000,000 £100,000.00

Director Shareholdings

Notifier Holding Value*
Cathal Friel 41,219,757 £0
Ian O’Connel 8,326,839 £0
Jeremy Skillington 1,028,261 £0

Major Shareholders

Notifier** Holding Value*
Roaring Waters Capital 40,000,000 £0
Michael Kelly 35,443,132 £0
Schroder Investment Management 24,994,777 £0
Allan Rankin 16,216,038 £0

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 5.00p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 6.00p
52 Week Low 2.00p
Volume 0
Shares Issued 697.20m
Beta 1.02

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.79% below the market average53.79% below the market average53.79% below the market average53.79% below the market average53.79% below the market average
7.32% below the sector average7.32% below the sector average7.32% below the sector average7.32% below the sector average7.32% below the sector average
Price Trend
87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average
77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 15-Jan-2026

Time Volume / Share Price
10:28 2,110 @ 4.96p
10:05 6,000 @ 4.88p
09:47 65 @ 5.18p
09:43 49,187 @ 4.88p
09:22 32,965 @ 4.89p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page